Golimumab
Golimumab (CNTO-148) is a potent humanized anti-TNFα IgG1κ monoclonal antibody with anti-inflammatory and anticancer activity. It inhibits the production of IL-6 and IL-1β, induces apoptosis, and can be used to prevent inflammation and destruction of cartilage or bone. This makes Golimumab valuable for studying rheumatoid arthritis and cancer.
Product Specifications
CAS Number
476181-74-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
146.93KD
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
TNF
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2706013-01 24 Strip Well
Human Purinergic Receptor P2Y, G Protein Coupled 12 (P2RY12) ELISA Kit
Sign In for Pricing
View Details MBS2706013-02 48 Well
Human Purinergic Receptor P2Y, G Protein Coupled 12 (P2RY12) ELISA Kit
Sign In for Pricing
View Details 
MBS2706013-03 96 Well
Human Purinergic Receptor P2Y, G Protein Coupled 12 (P2RY12) ELISA Kit
Sign In for Pricing
View Details 
MBS2706013-04 5x 96 Well
Human Purinergic Receptor P2Y, G Protein Coupled 12 (P2RY12) ELISA Kit
Sign In for Pricing
View Details MBS2706013-05 10x 96 Well
Human Purinergic Receptor P2Y, G Protein Coupled 12 (P2RY12) ELISA Kit
Sign In for Pricing
View Details 